Benign Tumors & Hyperplasia

Link to PubMed Peer-Reviewed Articles

Benign Prostate Hypertrophy

One of the more dramatic effects of SPDT treatment is the observed virtual elimination of symptoms of 'enlarged Prostate".  This condition is virtually universal in older men with the usual symptoms of getting up at night to urinate, frequency, intermittency, hesitancy, etc.  Following SPDT a near-complete resolution of this condition has been noted by patients having treatment for associated problems; the elimination of the symptoms was merely a 'side' benefit.  The likely outcome is this procedure may well be a replacement for the present standard treatment which is 'transurethral resection' or TURP.  Not unusual surgical complications include impotence, incontinence, infections, pain, hematuria, huge costs, etc.  A painless, effective, low-cost alternative, if available, would be the overwhelming choice for most men.

A study has shown PDT's effectiveness against hypertrophic cells from a typical patient with 'benign prostatic hypertrophy' or 'enlarged prostate'.

And here is a 'streaming' video of the benefits to flow in a SPDT patient with the diagnosis of 'benign prostatic hypertrophy' or 'enlarged prostate/ one week after treatment for another SPDT indication.  This was a bonus positive effect of the treatment. Another patient, age 80, reported independently similar noticeable improvements in 'stream'

 

 

Click Below for the 'Streaming Video

Benign NeuroFibroma Tumors

Another noteworthy category of 'benign' tumors reported benefitting from PDT/SPDT therapy is that of 'neurofibromatosis".

From Wikipedia:  Neurofibromatosis (NF) is a group of three conditions in which tumors grow in the nervous system.  The three types are neurofibromatosis type I (NF1), neurofibromatosis type II (NF2), and schwannomatosis.

The tumors in NF are generally non-cancerous

There is no known prevention or cure.  This is inaccurate.  Clinicians treating a thyroid cancer patient with PDT with skin neurofibroma have noted the dramatic reduction in size of the benign neurofibroma. See this article showing the benefits of PDT (with a very weak photosensitizer!) in combination with an antibiotic for treating nerve sheath neurofibroma tumor cells.

Surgery may be done to remove tumors that are causing problems or have become cancer in the old paradigm..  Radiation and chemotherapy may also be used if cancer occurs   A cochlear implant or auditory brainstem implant may help some who have hearing loss due to the condition. In the United States, about 1 in 3,500 people have NF1 and 1 in 25,000 have NF2.  Males and females are affected equally often.   In NF1, symptoms are often present at birth or develop before 10 years of age.  While the condition typically worsens with time, most people with NF1 have a normal life expectancy.   In NF2, symptoms may not become apparent until early adulthood. NF2 increases the risk of early death.

Neurofibromatosis therapy could be completely transformed with the PDT and SPDT platform being approved and available.

Below is an image of elderly lady with type 1 Neurofibromatosis.  Can you imagine the excitement of these patients having available in the near future a non-surgical, safe, convenient, outpatient procedure to reduce or eliminate these neurofibromas?

 

Screenshot 2020-03-18 at 17.31.17

Back of elderly patient with Neurofibromatosis type 1